Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults

NCT04840849 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Evaluate PK Profile

Interventions

BIOLOGICAL: nirsevimab
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]